Regeneron shared on LinkedIn:
”What can people who are naturally protected from diseases teach us about developing new medicines?
At Regeneron Genetics Center (RGC), researchers search for the rare ‘superhumans’ whose genetics may reveal protective factors hidden in human biology. After more than a decade of studying these signals at scale, RGC has uncovered more than 100 compelling genetic stories, and translated ~50 of them into potential medicines across Regeneron’s pipeline.
Aris Baras, Senior Vice President and Head of Regeneron Genetics Center, joined host Ben Comer on the Business of Biotech podcast to discuss how these discoveries are helping drive innovation.”
Other articles about Regeneron on OncoDaily.